durapatite has been researched along with bendamustine hydrochloride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gurjar, BS; Iqbal, Z; Kumar, V; Leekha, A; Rawat, P; Sharma, H; Talegaonkar, S; Thomas, SC; Tyagi, A; Verma, AK | 1 |
| Iqbal, Z; Madaan, T; Talegaonkar, S; Thomas, SC | 1 |
2 other study(ies) available for durapatite and bendamustine hydrochloride
| Article | Year |
|---|---|
Synergistic anticancer efficacy of Bendamustine Hydrochloride loaded bioactive Hydroxyapatite nanoparticles: In-vitro, ex-vivo and in-vivo evaluation.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bendamustine Hydrochloride; Carcinoma, Ehrlich Tumor; Drug Carriers; Drug Delivery Systems; Durapatite; Humans; In Vitro Techniques; Jurkat Cells; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Rats; Rats, Wistar | 2016 |
Box-Behnken Design of Experiment Assisted Development and Optimization of Bendamustine HCl loaded Hydroxyapatite Nanoparticles.
Topics: Animals; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Drug Compounding; Durapatite; Hydrogen-Ion Concentration; Male; Nanoparticles; Particle Size; Rats; Rats, Wistar; Surface Properties; Tissue Distribution | 2018 |